Cough Suppressant Drugs Market Introduction

Cough is a reflex action that clears the throat of mucus or any sort of foreign irritants. Coughing is the most common symptom of a number of medical conditions. According to a study published in the Journal of the Association of Physicians of India, cough is the sixth most common reason for hospital outpatient department visit. Factors that increase the risk of dry cough include exposure to pollutants/environmental irritants, residence close to heavy traffic leading to respiratory problems, cigarette smoking, asthma, chronic obstructive airway disease, use of angiotensin converting enzyme, acute & chronic infections, airway diseases, parenchymal disease, cardiovascular, and gastrointestinal.

Based on type, cough can be divided into acute cough and chronic cough. Cough suppressants are also known as antitussives. Cough suppressants inhibit cough coordinating region in the brain stem. High prevalence of cough is projected to increase demand for cough suppressant drugs during the forecast period, which in turn is anticipated to drive the global cough suppressant drugs market.

Identify the key factors that will drive your company’s growth, Request a brochure of this report here

Cough Suppressant Drugs Market – Competitive Landscape

The global cough suppressant drugs market is highly fragmented with several domestic players holding key market share in respective region. The low cost of manufacturing, easy availability of these products, large volume business for cough suppressant drugs and easy entry for new players into cough suppressant drugs market. All these factors have attracted large number of domestic manufacturers into this field. Major players operating in the global cough suppressant drugs market focus on business expansion and are engaged in mergers and collaborations.

Perrigo Company plc

Perrigo Company plc is an Ireland-based company that generates 70% of its revenue from the U.S. and has significant presence in the global cough suppressant drugs market. The Company is a leading provider of over-the-counter health and wellness solutions.

Pfizer, Inc

Pfizer, Inc. is another multinational company with strong presence in the cough suppressant drugs market in North America. Pfizer Inc. is a global pharmaceutical company that develops, manufactures, and markets prescription medicines in 11 therapeutic segments, including cardiovascular, oncology, neuroscience, pain, and infectious diseases. It operates through two business units: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH).

GlaxoSmithKline

GlaxoSmithKline is a global pharmaceutical company actively involved in research, development and manufacturing innovative pharmaceutical medicines, vaccines and consumer healthcare products. In 2018, GlaxoSmithKline invested around 4.60 Mn USD for research and development of pipeline products.

Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd. is a key producer of generic medicines and a recognized leader in innovative and specialty pharmaceuticals worldwide. The company delivers high-quality and patient-centric health care solutions across the globe. It has a wide generic product portfolio with more than 35,000 products in almost every therapeutic area.The company primarily operates through two business segments : Generic medicines and specialty medicines.Teva Pharmaceutical Industries Ltd. markets its gout therapeutic drug under its generic medicines business segment

Other players operating in the global cough suppressant drugs market include Tris Pharma, Inc., Aytu BioScience, Inc., Mayne Pharma Group Limited, and Acella Pharmaceuticals, LLC.

Expanding operations in future? To get the perfect launch ask for a custom report here

Cough Suppressant Drugs Market – Dynamics

Anticipated launch and commercialization will drive the cough suppressant drugs market.

A large number of drug candidates are in different stages of clinical trial approval in the U.S. and Europe. The anticipated launch and commercialization of these products is expected to propel the global cough suppressant drugs market during the forecast period.

The cough suppressant drugs market to grow with high prevalence of cough.

According to the Journal of the Association of Physicians of India data, around 54% of population of India suffered from Cough. The global cough suppressant drugs market is projected to expand at a rapid pace during the forecast period. Increase in the geriatric population, changes in lifestyle, and rise in health care awareness are the major factors driving the global market.

Favorable health care policies lead to an increase in affordability of various health care treatments. This, in turn, increases the life expectancy of the population. The population aged above 65 years usually suffers from various health disorders. Hence, increase in the geriatric population augments the global cough suppressant drugs market. However, stringent government regulations for sale of over-the-counter cough suppressant drugs are likely to restrain the global cough suppressant drugs market.

Cough Suppressant Drugs Market – Segmentation

On the basis of drug type, the global market can be divided into

  • Dextromethorphan
  • Codeine
  • Noscapine
  • Butramirate
  • Bennzonatate
  • Pholcodine

On the basis of dosage form, the global market can be divided into

  • Syrup
  • Tablet

On the basis of distribution channel, the global market can be divided into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others (specialty clinics)

The report on cough suppressant drugs market is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The cough suppressant drugs market report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The cough suppressant drugs market report also maps the qualitative impact of various market factors on market segments and geographies.

Regional analysis for cough suppressant drugs market includes:

  • North America
  • Europe.
  • Asia Pacific
  • Latin America
  • Middle East & Africa

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.